| Oct 3 |
Constellation Brands, Levi Strauss And 3 Stocks To Watch Heading Into Thursday
|
| Sep 3 |
Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September
|
| Aug 19 |
Processa Pharmaceuticals Announces Positive Preclinical Data for NGC-Iri
|
| Jul 30 |
FDA approves Processa Phase 2 study for NGC-Cap, stock rallies 46%
|
| Jul 30 |
Processa Pharmaceuticals Announces FDA Clearance of IND Application for a Phase 2 Clinical Trial of NGC-Cap in Breast Cancer
|
| Jul 17 |
Processa Pharmaceuticals appoints CFO
|
| Jul 17 |
Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial Officer
|
| Jun 11 |
Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer
|
| May 6 |
Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
|
